UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Health impact of dietary neoformed Maillard products in young healthy adults: occurrence in heat-treated foods and bioavailability

Proceedings of the Nutrition Society, 2008-05, Vol.67 (OCE5), Article E190

2008

Volltextzugriff (PDF)

Health impact of dietary neoformed Maillard products in young healthy adults: biological impact of high v. low dietary level

Proceedings of the Nutrition Society, 2008-05, Vol.67 (OCE5), Article E191

2008

Volltextzugriff (PDF)

Topical Transforming Growth Factor-β3 in the Prevention or Alleviation of Chemotherapy-Induced Oral Mucositis in Patients with Lymphomas or Solid Tumors

Journal of immunotherapy (1997), 2001-07, Vol.24 (4), p.384-388

2001

Volltextzugriff (PDF)

Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer

European journal of cancer (1990), 2003-05, Vol.39 (8), p.1089-1096

2003

Volltextzugriff (PDF)

Selective modulation of lipopolysaccharide-induced death and cytokine production by various muramyl peptides

Infection and Immunity, 1995-01, Vol.63 (1), p.110-115

1995

Volltextzugriff (PDF)

Differential Elimination of Synthetic Butyric Triglycerides In Vivo: A Pharmacokinetic Study

Journal of pharmaceutical sciences, 1993-10, Vol.82 (10), p.1046-1048

1993

Volltextzugriff (PDF)

Five years update of sequential high dose doxorubicin, cyclophosphamide and docetaxel in inflammatory breast cancer; PEGAGE05 trial on behalf of FNLCC

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.10773-10773

2006

Volltextzugriff (PDF)

Health impact of dietary neoformed Maillard products in young healthy adults: biological impact of high v . low dietary level

Proceedings of the Nutrition Society, 2008-05, Vol.67 (OCE5), Article E191

2008

Volltextzugriff (PDF)

Health impact of dietary neoformed Maillard products in young healthy adults: occurrence in heat-treated foods and bioavailability

Proceedings of the Nutrition Society, 2008-05, Vol.67 (OCE5), Article E190

2008

Volltextzugriff (PDF)

Enhancement by muramyl peptides of the protective response of interferon-α/β against encephalomyocarditis virus infection

International journal of immunopharmacology, 1996-03, Vol.18 (3), p.183-192

1996

Volltextzugriff (PDF)

Interferon α-2a and Dacarbazine in Melanoma

JNCI : Journal of the National Cancer Institute, 1990-06, Vol.82 (12), p.1062-1063

1990

Volltextzugriff (PDF)

Metastatic Breast Tumour Regression Following Treatment by a Gene‐Modified Vaccinia Virus Expressing MUC1 and IL‐2

BioMed research international, 2003, Vol.2003 (3), p.194-201

2003

Volltextzugriff (PDF)

Enhancement in vivo of the antiinflammatory and antitumor activities of type I interferon by association with the synthetic immunomodulator murabutide

Journal of interferon & cytokine research, 1996-04, Vol.16 (4), p.297-306

1996

Volltextzugriff (PDF)

Overexpression of PDGF receptor β in dermal fibroblasts of lymphangitic post radiotherapy relapses of breast carcinoma

Breast (Edinburgh), 1997-08, Vol.6 (4), p.206-211

1997

Volltextzugriff (PDF)

Targeting HER2 in other tumor types

Annals of oncology, 2001, Vol.12 (suppl-1), p.S81-S87

2001

Volltextzugriff (PDF)

Relevance of multiple biological parameters in breast cancer prognosis

Breast (Edinburgh), 1996-02, Vol.5 (1), p.21-30

1996

Volltextzugriff (PDF)

Clinical significance of tumoral cells detection by immunocytochemistry in bone marrow (BM) of metastatic breast cancer (MBC) patients

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.702-702

2005

Volltextzugriff (PDF)

Docetaxel in elderly patients: Phase I and pharmacokinetic study

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.2113-2113

2005

Volltextzugriff (PDF)

Angiosarcomas: Natural history and prognostic factors from 161 cases in three French institutions

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.9024-9024

2005

Volltextzugriff (PDF)

Breast cancer in young women age < 36 years: A retrospective analysis of prognostic factors in 926 patients in 8 french instituitions. GETNA group

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.9685-9685

2005

Volltextzugriff (PDF)

Dose-intensified chemotherapy and additional Docetaxel may improve inflammatory breast cancer patients outcome over two decades: Results from Institut Curie protocols 1977–1987 and two consecutive French multicenter trials Pegase 02 (1995–96) and Pegase 05 (1997–99)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.848-848

2004

Volltextzugriff (PDF)

Dose-intensified chemotherapy and additional Docetaxel may improve inflammatory breast cancer patients outcome over two decades: Results from Institut Curie protocols 1977–1987 and two consecutive French multicenter trials Pegase 02 (1995–96) and Pegase 05 (1997–99)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.848-848

2004

Volltextzugriff (PDF)

HER2 gene status assessment in micrometastatic cells in bone marrow (BM) of breast cancer patients by fluorescence in situ hybridization (FISH)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9520-9520

2004

Volltextzugriff (PDF)

Study of the prognostic value and chemosensitivity according to the type of translocation in synovial sarcoma

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9016-9016

2004

Volltextzugriff (PDF)

Study of the prognostic value and chemosensitivity according to the type of translocation in synovial sarcoma

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9016-9016

2004

Volltextzugriff (PDF)

1 – 25 von 109

Suche als RSS-Feed

Aktive Filter

ThemaHumans

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(92)

Publikationsform

Sprache

Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(18)
Medical Sciences
(18)
Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Animals
(13)
Mice
(12)
Pharmacology. Drug Treatments
(12)
Antineoplastic Agents
(11)
Oncology
(9)
Immunology
(6)
Chemotherapy
(5)
Drug Synergism
(4)
Life Sciences
(4)
Acetylmuramyl-Alanyl-Isoglutamine - Analogs & Derivatives
(3)
Adjuvants, Immunologic - Therapeutic Use
(3)
Bcg Vaccine
(3)
Butyrates - Pharmacology
(3)
Female
(3)
Immunotherapy
(3)
Leukemia L1210 - Immunology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Health impact of dietary neoformed Maillard products in young healthy adults: occurrence in heat-treated foods and bioavailability

Health impact of dietary neoformed Maillard products in young healthy adults: biological impact of high v. low dietary level

Topical Transforming Growth Factor-β3 in the Prevention or Alleviation of Chemotherapy-Induced Oral Mucositis in Patients with Lymphomas or Solid Tumors

Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer

Selective modulation of lipopolysaccharide-induced death and cytokine production by various muramyl peptides

Differential Elimination of Synthetic Butyric Triglycerides In Vivo: A Pharmacokinetic Study

Five years update of sequential high dose doxorubicin, cyclophosphamide and docetaxel in inflammatory breast cancer; PEGAGE05 trial on behalf of FNLCC

Health impact of dietary neoformed Maillard products in young healthy adults: biological impact of high v . low dietary level

Health impact of dietary neoformed Maillard products in young healthy adults: occurrence in heat-treated foods and bioavailability

Enhancement by muramyl peptides of the protective response of interferon-α/β against encephalomyocarditis virus infection

Interferon α-2a and Dacarbazine in Melanoma

Metastatic Breast Tumour Regression Following Treatment by a Gene‐Modified Vaccinia Virus Expressing MUC1 and IL‐2

Enhancement in vivo of the antiinflammatory and antitumor activities of type I interferon by association with the synthetic immunomodulator murabutide

Overexpression of PDGF receptor β in dermal fibroblasts of lymphangitic post radiotherapy relapses of breast carcinoma

Targeting HER2 in other tumor types

Relevance of multiple biological parameters in breast cancer prognosis

Clinical significance of tumoral cells detection by immunocytochemistry in bone marrow (BM) of metastatic breast cancer (MBC) patients

Docetaxel in elderly patients: Phase I and pharmacokinetic study

Angiosarcomas: Natural history and prognostic factors from 161 cases in three French institutions

Breast cancer in young women age < 36 years: A retrospective analysis of prognostic factors in 926 patients in 8 french instituitions. GETNA group

Dose-intensified chemotherapy and additional Docetaxel may improve inflammatory breast cancer patients outcome over two decades: Results from Institut Curie protocols 1977–1987 and two consecutive French multicenter trials Pegase 02 (1995–96) and Pegase 05 (1997–99)

Dose-intensified chemotherapy and additional Docetaxel may improve inflammatory breast cancer patients outcome over two decades: Results from Institut Curie protocols 1977–1987 and two consecutive French multicenter trials Pegase 02 (1995–96) and Pegase 05 (1997–99)

HER2 gene status assessment in micrometastatic cells in bone marrow (BM) of breast cancer patients by fluorescence in situ hybridization (FISH)

Study of the prognostic value and chemosensitivity according to the type of translocation in synovial sarcoma

Study of the prognostic value and chemosensitivity according to the type of translocation in synovial sarcoma

Aktive Filter

Suchergebnisse filtern